# Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

> **NCT03360708** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 20 (actual)

## Conditions studied

- Giant Cell Glioblastoma
- Recurrent Glioblastoma
- Recurrent Gliosarcoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **BIOLOGICAL:** Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine

## Key facts

- **NCT ID:** NCT03360708
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-27
- **Primary completion:** 2021-06-02
- **Final completion:** 2021-06-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03360708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03360708, "Vaccine Therapy in Treating Patients With Recurrent Glioblastoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03360708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*